|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
2 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development expense | |||||
| Expense for share retain | |||||
| Total operating costs and expenses | |||||
| Operating loss | |||||
| Other income (expenses): | |||||
| Other expense, net | |||||
| Interest income | |||||
| Interest expense, net | |||||
| Total other expense, net | |||||
| Net income (loss) before income taxes | |||||
| Net loss | |||||
| Less: Change in fair value and income impact of option liabilities | |||||
| Net income (loss) - diluted | |||||
| Basic net loss per share | |||||
| Total basic net loss per share | |||||
| Diluted net loss per share | |||||
| Basic weighted-average common shares outstanding | |||||
| Total basic weighted-average common shares outstanding | |||||
| Diluted weighted-average common shares outstanding | |||||
| Comprehensive loss: | |||||
| Foreign currency translation adjustment | |||||
| Total comprehensive loss | |||||
Loading...